AI assistant
Jazz Pharmaceuticals plc — Director's Dealing 2016
May 26, 2016
30751_dirs_2016-05-26_c365bd16-b03b-4d41-b586-57d34c35ef85.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2016-05-24
Reporting Person: Mulligan Seamus (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-24 | Ordinary Shares | S | 1400.0 | $148.6464 | Disposed | 1101179 | Direct |
| 2016-05-24 | Ordinary Shares | S | 11888.0 | $149.6377 | Disposed | 1089291 | Direct |
| 2016-05-24 | Ordinary Shares | S | 9954.0 | $150.7238 | Disposed | 1079337 | Direct |
| 2016-05-24 | Ordinary Shares | S | 4726.0 | $151.51 | Disposed | 1074611 | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.18 to $149.14. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F3: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $149.18 to $150.17. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F4: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $150.18 to $151.17. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F5: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $151.18 to $151.77. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.